Enanta Pharmaceuticals (ENTA) Q2 2026 Earnings

11MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-1.02
-0.82
-0.62
-0.42

Details

Expected EPS
-0.487337
Actual EPS
-0.45
Surprise EPS
0.04
Surprise Percent
+7.66%

Description

Enanta Pharmaceuticals (ENTA) has reported earnings of -0.45 per share for Q2 2026.

0 Comments

Share your thoughts